GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (FRA:NG2) » Definitions » Sale Of Investment

Neogen (FRA:NG2) Sale Of Investment : €100.5 Mil (TTM As of Feb. 2024)


View and export this data going back to 1989. Start your Free Trial

What is Neogen Sale Of Investment?

Neogen's sale of investment for the three months ended in Feb. 2024 was €16.2 Mil. It means Neogen gained €16.2 Mil from selling investments. Neogen's sale of investment for the trailing twelve months (TTM) ended in Feb. 2024 was €100.5 Mil.

Compared with last quarter (€33.2 Mil in Nov. 2023 ), Neogen gained less money from selling investments in Feb. 2024 (€16.2 Mil).

Neogen Sale Of Investment Historical Data

The historical data trend for Neogen's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neogen Sale Of Investment Chart

Neogen Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 303.27 372.97 629.26 361.22 245.43

Neogen Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.28 31.05 20.09 33.19 16.21

Neogen Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €100.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neogen Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Neogen's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Neogen (FRA:NG2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (FRA:NG2) » Definitions » Sale Of Investment
Comparable Companies
GH SHC TWST NEO RDNT MYGN VCYT LAB OPK FLGT TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT
Traded in Other Exchanges
NEOG:USA NG2:Germany
Address
620 Lesher Place, Lansing, MI, USA, 48912
Website
https://www.neogen.com
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.

Neogen (FRA:NG2) Headlines

No Headlines